A new Shared Care Agreement (SCA) for subcutaneous methotrexate has been approved for use in adult patients with psoriasis or eczema and other inflammatory skin conditions.
New Shared Care Agreement: Methotrexate for Dermatology Indications
Posted: Wednesday, February 23, 2022
Category - Medicines Update